{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:37:12Z","timestamp":1790775432790,"version":"4.1.0"},"reference-count":49,"publisher":"The Endocrine Society","issue":"3","license":[{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>To examine prescription of guideline-recommended therapies and achievement of treatment targets across the span of older adulthood in type 1 diabetes (T1D) in the United States and Germany\/Austria.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods<\/jats:title>\n                    <jats:p>Cross-sectional data of adults aged \u226560 years with T1D for \u22651 year seen in 2022 in the T1D Exchange Quality Improvement Collaborative (T1DX-QI) and the Diabetes Prospective Follow-up (DPV) registry. Descriptive statistics and within-registry comparisons across age groups using analysis of variance and chi-squared tests were used to analyze the data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Thirty-six hundred adults aged \u226560 years, median age 67.5 [interquartile range (IQR) 63.4, 72.8] in T1DX-QI (n = 1549) and 68.9 (IQR 63.6, 75.7) in DPV (n = 2051) were included. The prevalence of atherosclerotic cardiovascular disease (ASCVD) (34.6% vs 16.8%) and chronic kidney disease (28.5% vs 11.8%) was higher in the DPV than the T1DX-QI. Lipid-lowering therapy for secondary prevention (52.9% vs 38%) and angiotensin-converting enzyme inhibitor\/angiotensin receptor blocker use (55.3% vs 44.8%) were higher in the DPV. Continuous glucose monitoring use was similar (50.3% vs 47.9%), insulin pump use was &amp;gt;2 \u00d7 higher (40.7% vs 17%), and automated insulin delivery use was &amp;gt;3 \u00d7 higher (20.4% vs 6.4%) in the T1DX-QI as compared to the DPV.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Despite a high prevalence of ASCVD and risks of hypoglycemia, guideline-recommended treatments including lipid-lowering therapy for secondary prevention and diabetes technologies were used in approximately half or fewer of older adults with T1D. Additional attention to prescribing and practices to support clinicians and older adults in the use of diabetes technologies is urgently needed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/jendso\/bvag007","type":"journal-article","created":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T12:42:17Z","timestamp":1768480937000},"source":"Crossref","is-referenced-by-count":1,"title":["Missed opportunities for risk reduction: type 1 diabetes management in older adults in DPV and T1DX-QI registries"],"prefix":"10.1210","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2949-9568","authenticated-orcid":false,"given":"Kathryn L","family":"Fantasia","sequence":"first","affiliation":[{"name":"Department of Medicine, Section of Endocrinology, Diabetes, Nutrition and Weight Management, Boston University Chobanian and Avedisian School of Medicine , Boston, MA 02118 ,","place":["USA"]},{"name":"Department of Medicine, Evans Center for Implementation and Improvement Sciences, Boston University Chobanian and Avedisian School of Medicine , Boston, MA 02118 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Lanzinger","sequence":"additional","affiliation":[{"name":"CAQM, University of Ulm , Ulm 89081 ,","place":["Germany"]},{"name":"German Center for Diabetes Research (DZD) , Munich-Neuherberg 85764 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saketh","family":"Rompicherla","sequence":"additional","affiliation":[{"name":"T1D Exchange , Boston, MA 02110 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer J","family":"Grammes","sequence":"additional","affiliation":[{"name":"Health Psychology, Johannes Gutenberg University , Mainz 55099 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grenye","family":"O\u2019Malley","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Endocrinology, Icahn School of Medicine at Mount Sinai , New York, NY 10029 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia K","family":"Mader","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Endocrinology and Diabetology, Medical University of Graz , Graz 8036 ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Golden","sequence":"additional","affiliation":[{"name":"Center for Diabetes and Metabolic Health, New York University Langone Health , New York, NY 10017 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Kopp","sequence":"additional","affiliation":[{"name":"Diabetes Center, University of Augsburg , Augsburg 86159 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4602-7909","authenticated-orcid":false,"given":"David M","family":"Maahs","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Endocrinology, Stanford University , Stanford, CA 94304 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M","family":"Jehle","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Martin-Luther-University, Halle-Wittenberg , Lutherstadt Wittenberg 06886 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osagie","family":"Ebekozien","sequence":"additional","affiliation":[{"name":"T1D Exchange , Boston, MA 02110 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard W","family":"Holl","sequence":"additional","affiliation":[{"name":"CAQM, University of Ulm , Ulm 89081 ,","place":["Germany"]},{"name":"German Center for Diabetes Research (DZD) , Munich-Neuherberg 85764 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2026,1,19]]},"reference":[{"key":"2026021903313032900_bvag007-B1","doi-asserted-by":"crossref","first-page":"e078432","DOI":"10.1136\/bmj-2023-078432","article-title":"Global burden of type 1 diabetes in adults aged 65 years and older, 1990-2019: population based study","volume":"385","author":"Yang","year":"2024","journal-title":"BMJ"},{"issue":"11","key":"2026021903313032900_bvag007-B2","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.2337\/dc21-0770","article-title":"Adult-onset type 1 diabetes: current understanding and challenges","volume":"44","author":"David Leslie","year":"2021","journal-title":"Diabetes Care"},{"issue":"10","key":"2026021903313032900_bvag007-B3","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S2213-8587(22)00218-2","article-title":"Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: a modelling study","volume":"10","author":"Gregory","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"2026021903313032900_bvag007-B4","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1007\/s00125-022-05659-9","article-title":"Mortality trends in type 1 diabetes: a multicountry analysis of six population-based cohorts","volume":"65","author":"Ruiz","year":"2022","journal-title":"Diabetologia"},{"key":"2026021903313032900_bvag007-B5","first-page":"1","volume-title":"Diabetes in America","author":"Secrest","year":"2018","edition":"3rd ed"},{"issue":"8","key":"2026021903313032900_bvag007-B6","doi-asserted-by":"crossref","first-page":"e347","DOI":"10.1161\/CIR.0000000000001209","article-title":"2024 heart disease and stroke statistics: a report of US and global data from the American Heart Association","volume":"149","author":"Martin","year":"2024","journal-title":"Circulation"},{"issue":"3","key":"2026021903313032900_bvag007-B7","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2337\/dc19-0906","article-title":"Severe hypoglycemia and cognitive function in older adults with type 1 diabetes: the study of longevity in diabetes (SOLID)","volume":"43","author":"Lacy","year":"2020","journal-title":"Diabetes Care"},{"issue":"1","key":"2026021903313032900_bvag007-B8","doi-asserted-by":"crossref","first-page":"248","DOI":"10.2337\/dc20-0552","article-title":"Severe hypoglycemia, cardiac structure and function, and risk of cardiovascular events among older adults with diabetes","volume":"44","author":"Echouffo-Tcheugui","year":"2021","journal-title":"Diabetes Care"},{"key":"2026021903313032900_bvag007-B9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fendo.2021.571568","article-title":"Meta-analysis: association between hypoglycemia and serious adverse events in older patients treated with glucose-lowering agents","volume":"12","author":"Mattishent","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"8","key":"2026021903313032900_bvag007-B10","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1210\/jc.2013-1589","article-title":"Severe hypoglycemia and diabetic ketoacidosis in adults with type 1 diabetes: results from the T1D exchange clinic registry","volume":"98","author":"Weinstock","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2026021903313032900_bvag007-B11","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.2337\/dc19-0830","article-title":"Incidences of severe hypoglycemia and diabetic ketoacidosis and prevalence of microvascular complications stratified by age and glycemic control in U.S. adult patientswith type 1 diabetes: a real-world study","volume":"42","author":"Pettus","year":"2019","journal-title":"Diabetes Care"},{"issue":"13","key":"2026021903313032900_bvag007-B12","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMra2311526","article-title":"Prevention of cardiovascular disease in type 1 diabetes","volume":"390","author":"Manrique-Acevedo","year":"2024","journal-title":"N Engl J Med"},{"issue":"23","key":"2026021903313032900_bvag007-B13","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1001\/jama.2020.6928","article-title":"Effect of continuous glucose monitoring on hypoglycemia in older adults with type 1 diabetes: a randomized clinical trial","volume":"323","author":"Pratley","year":"2020","journal-title":"JAMA"},{"issue":"1","key":"2026021903313032900_bvag007-B14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/dia.2021.0246","article-title":"Use of technology in older adults with type 1 diabetes: clinical characteristics and glycemic metrics","volume":"24","author":"Munshi","year":"2022","journal-title":"Diabetes Technol Ther"},{"issue":"2","key":"2026021903313032900_bvag007-B15","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2337\/dc21-1667","article-title":"Closed-loop insulin delivery versus sensor-augmented pump therapy in older adults with type 1 diabetes (ORACL): a randomized, crossover trial","volume":"45","author":"McAuley","year":"2022","journal-title":"Diabetes Care"},{"issue":"9","key":"2026021903313032900_bvag007-B16","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1111\/dom.14069","article-title":"Undertreatment of cardiovascular risk factors in the type 1 diabetes exchange clinic network (United States) and the prospective diabetes follow-up (Germany\/Austria) registries","volume":"22","author":"Shah","year":"2020","journal-title":"Diabetes Obes Metab"},{"issue":"800","key":"2026021903313032900_bvag007-B17","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.diabres.2016.09.024","article-title":"Type 1 diabetes in older adults: comparing treatments and chronic complications in the United States T1D exchange and the German\/Austrian DPV registries","volume":"122","author":"Weinstock","year":"2016","journal-title":"Diabetes Res Clin Pract"},{"issue":"8","key":"2026021903313032900_bvag007-B18","doi-asserted-by":"crossref","first-page":"e0136339","DOI":"10.1371\/journal.pone.0136339","article-title":"Medication underuse in aging outpatients with cardiovascular disease: prevalence, determinants, and outcomes in a prospective cohort study","volume":"10","author":"Meid","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"2026021903313032900_bvag007-B19","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2165\/11631750-000000000-00000","article-title":"Underprescription of beneficial medicines in older people: causes, consequences and prevention","volume":"29","author":"Cherubini","year":"2012","journal-title":"Drugs Aging"},{"issue":"1","key":"2026021903313032900_bvag007-B20","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2337\/cd22-0072","article-title":"Making diabetes electronic medical record data actionable: promoting benchmarking and population health improvement using the T1D exchange quality improvement portal","volume":"41","author":"Mungmode","year":"2023","journal-title":"Clin Diabetes"},{"key":"2026021903313032900_bvag007-B21","first-page":"1","volume-title":"Ageing, Older Persons and the 2030 Agenda for Sustainable Development","author":"United Nations Development Programme","year":"2017"},{"issue":"2","key":"2026021903313032900_bvag007-B22","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1053\/j.ajkd.2021.08.003","article-title":"A unifying approach for GFR estimation: recommendations of the NKF-ASN task force on reassessing the inclusion of race in diagnosing kidney disease","volume":"79","author":"Delgado","year":"2022","journal-title":"Am J Kidney Dis"},{"key":"2026021903313032900_bvag007-B23","author":"Fantasia"},{"issue":"Supplement_1","key":"2026021903313032900_bvag007-B24","doi-asserted-by":"crossref","first-page":"S144","DOI":"10.2337\/dc22-S010","article-title":"10. Cardiovascular disease and risk management: standards of medical care in diabetes\u20142022","volume":"45","author":"Care","year":"2022","journal-title":"Diabetes Care"},{"issue":"9","key":"2026021903313032900_bvag007-B25","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.2337\/dc22-ad08a","article-title":"Addendum. 11. Chronic kidney disease and risk management: standards of medical care in diabetes-2022. Diabetes Care 2022;45(Suppl. 1): S175-S184","volume":"45","author":"American Diabetes Association Professional Practice Committee","year":"2022","journal-title":"Diabetes Care"},{"issue":"11","key":"2026021903313032900_bvag007-B26","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.2337\/dci21-0043","article-title":"The management of type 1 diabetes in adults. A consensus report by the American diabetes association (ADA) and the European association for the study of diabetes (EASD)","volume":"44","author":"Holt","year":"2021","journal-title":"Diabetes Care"},{"issue":"4","key":"2026021903313032900_bvag007-B27","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"J Clin Epidemiol"},{"issue":"25","key":"2026021903313032900_bvag007-B28","first-page":"e1046","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: executive summary: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"key":"2026021903313032900_bvag007-B29","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.atherosclerosis.2019.08.014","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"290","author":"Mach","year":"2019","journal-title":"Atherosclerosis"},{"issue":"23","key":"2026021903313032900_bvag007-B30","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMsa2032271","article-title":"Trends in diabetes treatment and control in U.S. Adults, 1999\u20132018","volume":"384","author":"Fang","year":"2021","journal-title":"N Engl J Med"},{"issue":"9","key":"2026021903313032900_bvag007-B31","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s11883-024-01224-4","article-title":"Cholesterol lowering in older adults: should we wait for further evidence?","volume":"26","author":"Jamil","year":"2024","journal-title":"Curr Atheroscler Rep"},{"issue":"7-8","key":"2026021903313032900_bvag007-B32","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1177\/0898264321991658","article-title":"Evidence for the 4Ms: interactions and outcomes across the care continuum","volume":"33","author":"Mate","year":"2021","journal-title":"J Aging Health"},{"issue":"15","key":"2026021903313032900_bvag007-B33","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1001\/jama.291.15.1864","article-title":"Lipid-lowering therapy with statins in high-risk elderly patients: the treatment-risk paradox","volume":"291","author":"Ko","year":"2004","journal-title":"JAMA"},{"issue":"2","key":"2026021903313032900_bvag007-B34","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jacl.2024.09.005","article-title":"Managing hypercholesterolemia in adults older than 75 years without a history of atherosclerotic cardiovascular disease: an expert clinical consensus from the national lipid association and the American geriatrics society","volume":"19","author":"Bittner","year":"2025","journal-title":"J Clin Lipidol"},{"issue":"2","key":"2026021903313032900_bvag007-B35","doi-asserted-by":"crossref","first-page":"e2457498","DOI":"10.1001\/jamanetworkopen.2024.57498","article-title":"Older adults\u2019 attitudes toward deprescribing in 14 countries","volume":"8","author":"L\u00fcthold","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"4","key":"2026021903313032900_bvag007-B36","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1177\/1932296816643542","article-title":"The impact of real-time continuous glucose monitoring in patients 65 years and older","volume":"10","author":"Polonsky","year":"2016","journal-title":"J Diabetes Sci Technol"},{"issue":"5","key":"2026021903313032900_bvag007-B37","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/dme.14218","article-title":"Comparative characteristics of older people with type 1 diabetes treated with continuous subcutaneous insulin infusion or insulin injection therapy: data from the German\/Austrian DPV registry","volume":"37","author":"Grammes","year":"2020","journal-title":"Diabet Med"},{"issue":"3","key":"2026021903313032900_bvag007-B38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/dme.15261","article-title":"Continuous glucose monitoring in older adults with diabetes: data from the diabetes prospective follow-up (DPV) registry","volume":"41","author":"Grammes","year":"2024","journal-title":"Diabet Med"},{"issue":"4","key":"2026021903313032900_bvag007-B39","doi-asserted-by":"crossref","first-page":"660","DOI":"10.2337\/dc23-1317","article-title":"Demographic, clinical, management, and outcome characteristics of 8,004 young children with type 1 diabetes","volume":"47","author":"Sandy","year":"2024","journal-title":"Diabetes Care"},{"issue":"2","key":"2026021903313032900_bvag007-B40","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1089\/dia.2018.0384","article-title":"State of type 1 diabetes management and outcomes from the T1D exchange in 2016\u20132018","volume":"21","author":"Foster","year":"2019","journal-title":"Diabetes Technol Ther"},{"issue":"12","key":"2026021903313032900_bvag007-B41","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1089\/dia.2022.0248","article-title":"Transatlantic comparison of pediatric continuous glucose monitoring use in the diabetes-patienten-verlaufsdokumentation initiative and type 1 diabetes exchange quality improvement collaborative","volume":"24","author":"Desalvo","year":"2022","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"2026021903313032900_bvag007-B42","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1177\/1932296820978769","article-title":"Perceived burdens and benefits associated with continuous glucose monitor use in type 1 diabetes across the lifespan","volume":"16","author":"Divan","year":"2022","journal-title":"J Diabetes Sci Technol"},{"issue":"4","key":"2026021903313032900_bvag007-B43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/dme.15264","article-title":"Real-world lived experience of older adults with type 1 diabetes after an automated insulin delivery trial","volume":"41","author":"Kubilay","year":"2024","journal-title":"Diabet Med"},{"issue":"6","key":"2026021903313032900_bvag007-B44","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1111\/dme.14252","article-title":"Health professionals\u2019 views about who would benefit from using a closed-loop system: a qualitative study","volume":"37","author":"Lawton","year":"2020","journal-title":"Diabet Med"},{"issue":"2","key":"2026021903313032900_bvag007-B45","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1089\/dia.2021.0311","article-title":"Closed-loop insulin therapy in older adults with type 1 diabetes: real-world data","volume":"24","author":"Toschi","year":"2022","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"2026021903313032900_bvag007-B46","doi-asserted-by":"crossref","first-page":"e0220857","DOI":"10.1371\/journal.pone.0220857","article-title":"Global reach of ageism on older persons\u2019 health: a systematic review","volume":"15","author":"Chang","year":"2020","journal-title":"PLoS One"},{"issue":"11","key":"2026021903313032900_bvag007-B47","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1089\/dia.2023.0320","article-title":"Longitudinal trends in glycemic outcomes and technology use for over 48,000 people with type 1 diabetes (2016-2022) from the type 1 diabetes exchange quality improvement collaborative","volume":"25","author":"Ebekozien","year":"2023","journal-title":"Diabetes Technol Ther"},{"issue":"7","key":"2026021903313032900_bvag007-B48","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.2337\/dc23-1982","article-title":"Receipt of diabetes specialty care and management services by older adults with diabetes in the United States, 2015\u20132019: an analysis of medicare fee-for-service claims","volume":"47","author":"Kahkoska","year":"2024","journal-title":"Diabetes Care"},{"issue":"7","key":"2026021903313032900_bvag007-B49","doi-asserted-by":"crossref","first-page":"E388","DOI":"10.1210\/clinem\/dgad046","article-title":"Racial\/ethnic inequities in use of diabetes technologies among medicare advantage beneficiaries with type 1 diabetes","volume":"108","author":"Kommareddi","year":"2023","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Journal of the Endocrine Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jes\/advance-article-pdf\/doi\/10.1210\/jendso\/bvag007\/66440587\/bvag007.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/10\/3\/bvag007\/66440587\/bvag007.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/10\/3\/bvag007\/66440587\/bvag007.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T08:31:41Z","timestamp":1771489901000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jes\/article\/doi\/10.1210\/jendso\/bvag007\/8428590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,19]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,2,6]]}},"URL":"https:\/\/doi.org\/10.1210\/jendso\/bvag007","relation":{},"ISSN":["2472-1972"],"issn-type":[{"value":"2472-1972","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3]]},"published":{"date-parts":[[2026,1,19]]},"article-number":"bvag007"}}